Review of regenerative and gene-expression research involving GHK-Cu
From celebrities to everyday patients, millions of people are now using medications like: Ozempic Wegovy Mounjaro Zepbound Saxenda These medications can help reduce appetite, improve blood sugar control, and support significant weight loss
Acute phase peptides (BPC-157, Pinealon) that address immediate neuroprotection and excitotoxicity could be started first
The evidence: Unapproved peptides have little, if any, human clinical trial data supporting safety or efficacy
By making a commitment to affordability and opening the door to greater collaboration to reduce out-of-pocket medication spending, we can ensure that more people are able to reap the health benefits of these critical medications
It is still investigational, with approval anticipated in late 2026 or 2027